Replimune Group, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US76029N1063
USD
7.71
-0.19 (-2.41%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryReplimune Group, Inc. VS Pharmaceuticals & Biotechnology
 
1D
-2.41%
0.03%
1W
9.52%
-0.35%
1M
-20.68%
0.08%
YTD
-20.68%
1.02%
1Y
-43.93%
13.02%
3Y
-71.98%
72.04%
5Y
-82.61%
80.03%
10Y
-82.61%
262.66%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-8.43%
0%
-8.43%
6 Months
131.18%
0%
131.18%
1 Year
-43.93%
0%
-43.93%
2 Years
-1.91%
0%
-1.91%
3 Years
-71.98%
0%
-71.98%
4 Years
-62.86%
0%
-62.86%
5 Years
-82.61%
0%
-82.61%

Replimune Group, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary